Skip to Content
Søk Menu
7.-11. SEPTEMBER 2022

Håll utkik när vi täcker EADV 2022 I European Academy of Dermatology and Venereology

Highlights • EADV 2022

Therapies for atopic dermatitis for special populations of patients

  • / April Armstrong

Severe atopic dermatitis in a pediatric population – Epidemiology, pathophysiology, and comorbidities

/ Ida Vittrup Nielsen
Atopisk dermatitEADV22 Play the Video

Short-term topical therapies and anti-IL-23 treatment updates for patients with nail psoriasis

/ BestPractice Nordic
PsoriasisEADV22Biologisk behandling

JAK inhibitors for patients with alopecia areata 

/ BestPractice Nordic
JAK-hämmareBarnEADV22Autoimmuna sjukdomar

EADV 2021

Annarita Antelmi

How to recognize and manage hair dye allergy

/ Annarita Antelmi
EADV21Allergi Play the Video
Eniko Sonkoly

Existing and upcoming small molecules in psoriasis treatment

/ Enikö Sonkoly
EADV21Psoriasis Play the Video
Filippa Nyberg

Sjögren’s syndrome is a common disease, but unfortunately neglected

/ Filippa Nyberg
EADV21 Play the Video
Álvaro González-Cantero

Vaccine hesitancy driven by safety concerns

/ Álvaro González-Cantero
COVID-19EADV21Psoriasis Play the Video

The risk of infections in psoriasis patients treated with biologics during the COVID-19 pandemic

/ Lara van der Schoot / Juul van den Reek
COVID-19EADV21Psoriasis Play the Video
Dimitrios Ioannides

Psoriasis has significant negative impact on quality of life

/ Dimitrios Loannides
EADV21Psoriasis Play the Video
Load more

Switching from biology treatment of AD to a JAK inhibitor resulted in improved efficacy

  • / Andrew Blauvelt

Missa inte de senaste nyheterna från Dermatologi

Registrera dig och få nya artiklar, MEDtalks, MEDcast, professionella tester och tidskrifter i din inkorg

Få tillgang

Mere från EADV 2020

EADV20: Complete treatment of psoriatic disease

/ Kristian Reich
EADV20Psoriasis Play the Video

EADV20: Baricitinib – the first JAK-inhibitor for treatment of patients with atopic dermatitis

/ Kristian Reich
EADV20Atopisk dermatitJAK-hämmare Play the Video

EADV20: Oral and topical treatment of Psoriasis now and in the future

/ Enikö Sonkoly
EADV20Psoriasis Play the Video

EADV20: Sonelokinab – an IL-17 A/F Nanobody®, which neutralizes both IL-17A and IL-17F in patients with moderate to severe chronic plaque-type psoriasis

/ Kim Papp
EADV20Psoriasis Play the Video

Abstract: Orala selektiva JAK-hämmare ­nya behandlingsmöjligheter av atopisk dermatit på väg

EADV20Atopisk dermatitJAK-hämmare

EADV20: Optimizing outcomes in moderate-to-severe atopic dermatitis

/ Lawrence Eichenfield
Atopisk dermatitEADV20 Play the Video
Back to top